PMID- 10415025 OWN - NLM STAT- MEDLINE DCOM- 19990812 LR - 20161124 IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 163 IP - 3 DP - 1999 Aug 1 TI - Direct suppression of TCR-mediated activation of extracellular signal-regulated kinase by leukocyte protein tyrosine phosphatase, a tyrosine-specific phosphatase. PG - 1282-8 AB - Leukocyte protein tyrosine phosphatase (LC-PTP)/hemopoietic PTP is a human cytoplasmic PTP that is predominantly expressed in the hemopoietic cells. Recently, it was reported that hemopoietic PTP inhibited TCR-mediated signal transduction. However, the precise mechanism of the inhibition was not identified. Here we report that extracellular signal-regulated kinase (ERK) is the direct target of LC-PTP. LC-PTP dephosphorylated ERK2 in vitro. Expression of wild-type LC-PTP in 293T cells suppressed the phosphorylation of ERK2 by a mutant MEK1, which was constitutively active regardless of upstream activation signals. No suppression of the phosphorylation was observed by LC-PTPCS, a catalytically inactive mutant. In Jurkat cells, LC-PTP suppressed the ERK and p38 mitogen-activated protein kinase cascades. LC-PTP and LC-PTPCS made complexes with ERK1, ERK2, and p38alpha, but not with the gain-of-function sevenmaker ERK2 mutant (D321N). A small deletion (aa 1-46) in the N-terminal portion of LC-PTP or Arg to Ala substitutions at aa 41 and 42 resulted in the loss of ERK binding activity. These LC-PTP mutants revealed little inhibition of the ERK cascade activated by TCR cross-linking. On the other hand, the wild-type LC-PTP did not suppress the phosphorylation of sevenmaker ERK2 mutant. Thus, the complex formation of LC-PTP with ERK is the essential mechanism for the suppression. Taken collectively, these results indicate that LC-PTP suppresses mitogen-activated protein kinase directly in vivo. FAU - Oh-hora, M AU - Oh-hora M AD - Biomedical Research Center, Osaka University Medical School, Japan. FAU - Ogata, M AU - Ogata M FAU - Mori, Y AU - Mori Y FAU - Adachi, M AU - Adachi M FAU - Imai, K AU - Imai K FAU - Kosugi, A AU - Kosugi A FAU - Hamaoka, T AU - Hamaoka T LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (Macromolecular Substances) RN - 0 (Receptors, Antigen, T-Cell) RN - 0 (Recombinant Fusion Proteins) RN - 42HK56048U (Tyrosine) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) RN - EC 2.7.11.1 (Protein-Serine-Threonine Kinases) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinases) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) RN - EC 2.7.12.2 (MAP Kinase Kinase 1) RN - EC 2.7.12.2 (MAP2K1 protein, human) RN - EC 2.7.12.2 (Mitogen-Activated Protein Kinase Kinases) RN - EC 3.1.3.48 (PTPN6 protein, human) RN - EC 3.1.3.48 (PTPN7 protein, human) RN - EC 3.1.3.48 (Protein Tyrosine Phosphatase, Non-Receptor Type 6) RN - EC 3.1.3.48 (Protein Tyrosine Phosphatases) RN - EC 3.1.3.48 (Protein Tyrosine Phosphatases, Non-Receptor) SB - AIM SB - IM MH - Calcium-Calmodulin-Dependent Protein Kinases/*antagonists & inhibitors/*metabolism MH - Cell Line MH - Enzyme Activation/immunology MH - Genetic Vectors/metabolism MH - Humans MH - Intracellular Signaling Peptides and Proteins MH - Jurkat Cells MH - Kidney MH - MAP Kinase Kinase 1 MH - Macromolecular Substances MH - *Mitogen-Activated Protein Kinase Kinases MH - *Mitogen-Activated Protein Kinases MH - Phosphorylation MH - Protein Binding/immunology MH - Protein Tyrosine Phosphatase, Non-Receptor Type 6 MH - Protein Tyrosine Phosphatases/genetics/*physiology MH - Protein Tyrosine Phosphatases, Non-Receptor MH - Protein-Serine-Threonine Kinases/genetics/metabolism MH - Protein-Tyrosine Kinases/genetics/metabolism MH - Receptors, Antigen, T-Cell/*physiology MH - Recombinant Fusion Proteins/biosynthesis/metabolism MH - Transfection MH - Tyrosine/*metabolism MH - p38 Mitogen-Activated Protein Kinases EDAT- 1999/07/22 00:00 MHDA- 1999/07/22 00:01 CRDT- 1999/07/22 00:00 PHST- 1999/07/22 00:00 [pubmed] PHST- 1999/07/22 00:01 [medline] PHST- 1999/07/22 00:00 [entrez] AID - ji_v163n3p1282 [pii] PST - ppublish SO - J Immunol. 1999 Aug 1;163(3):1282-8.